HYPD Stock Analysis: Buy, Sell, or Hold?
HYPD - Hyperion DeFi, Inc. Common Stock
$3.18
0.04 (1.27%)
▲
5d:
+16.91%
30d:
+20.45%
90d:
-18.46%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When HYPD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: HYPD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: HYPD shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.65
Based on -19.6% avg growth
INTRINSIC VALUE TODAY
$1.64
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HYPD is currently trading at $3.18, which is considered extended relative to its 30-day fair value range of $2.55 to $2.94. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.4) compared to its historical average (6.6). Remarkably, the market is currently pricing in an annual earnings decline of 28.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HYPD is in a downtrend. Immediate support is located at $2.56, while resistance sits at $3.57.
Market Sentiment: HYPD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.20 (+126.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HYPD is in a downtrend. Immediate support is located at $2.56, while resistance sits at $3.57.
Market Sentiment: HYPD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.20 (+126.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.55 -
$2.94
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
23.8%
All Signals
- BEARISH: Price extended above range (+8.2% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 126.4% below Wall St target ($7.20)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.55 -
$2.94
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.56
Resistance Level
$3.57
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.38
Wall Street Target
$7.20
(+126.4%)
Revenue Growth (YoY)
1559.5%
Profit Margin
474.9%
Valuation Discount vs History
-28.7% cheaper
PE vs Historical
2.4 vs 6.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-28.7%
(market-implied from PE analysis)
1-Year Target
$2.86
(-10%)
2-Year Target
$2.58
(-19%)
3-Year Target
$2.32
(-27%)
3-Yr Target (if PE normalizes)
(PE: 2→7)
$6.42
(+102%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: -43.2%)
$19.53
(+514%)
Base:
(SPY PE: 2.4, Growth: -43.2%)
$2.32
(-27%)
Bear:
(PE: 2.0, Growth: -43.2%)
$1.97
(-38%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.4 to 6.6
Stabilization Target:
$8.81
(+177.1%)
PE Expansion Potential:
+177.1%
Share & Embed Analysis
Last updated: August 24, 2026 8:03 AM ET
Data refreshes hourly during market hours. Next update: 9:03 AM
Data refreshes hourly during market hours. Next update: 9:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYPD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 33 SELL |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 39 SELL |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 26 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 55 HOLD |
